Andere talen AbbVie Inc. Buenos Aires S.E.

Aandelen

slotkoers Buenos Aires S.E. Andere beurzen 00:00:00 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
17 ^USD	-5,82%		-0,29%	+11,84%

01/07	Merus benoemt nieuwe Chief Medical Officer	MT
01/07	AbbVie zegt dat Robert Michael de rol van CEO overneemt	MT

AbbVie to Host Second-Quarter 2024 Earnings Conference Call	02/07
Merus Names New Chief Medical Officer	01/07
AbbVie : le nouveau directeur général prend ses fonctions	01/07
AbbVie Says Robert Michael Assumes CEO Role	01/07
Blackrock : Boeing, Meta...les valeurs à suivre aujourd'hui à Wall Street	01/07
AbbVie : Robert A. Michael prend les commandes d’AbbVie	01/07
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer	01/07
AbbVie Announces Board Changes	01/07
AbbVie - Introducing Alle Payment Plans, Powered by Cherry	28/06
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	28/06
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
Health Care Stocks Fall With Broad Market -- Health Care Roundup	27/06
Sector Update: Health Care Stocks Slipping Late Afternoon	27/06
Sector Update: Health Care Stocks Decline in Afternoon Trading	27/06
AbbVie : acquisition de Celsius pour 250 millions de dollars	27/06
AbbVie Buys Celsius Therapeutics for $250 Million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06

Geen resultaten voor deze zoekopdracht